Creative Planning Heron Therapeutics, Inc. Transaction History

Creative Planning

  • $129 Billion
  • Q3 2025

A detailed history of Creative Planning transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 12,409 shares of HRTX stock, worth $13,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,409
Previous 39,389 68.5%
Holding current value
$13,649
Previous $81,000 81.48%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$1.21 - $2.23 $32,645 - $60,165
-26,980 Reduced 68.5%
12,409 $15,000
Q2 2025

Aug 08, 2025
SELL
$1.72 - $2.42 $101,588 - $142,932
-59,063 Reduced 59.99%
39,389 $81,000
Q1 2025

May 15, 2025
BUY
$1.47 - $2.55 $144,724 - $251,052
98,452 New
98,452 $216,000

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $131M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email